Nevertheless, resistance to carbapenem can be caused by several mechanisms including production of enzymes such as carbapenemases Class A KPCs, Class B metallo β-lactamases IMP, VIM, NDM, or Class D OXA-type enzymes such as OXA-23, 12] . Class D β-lactamases or oxacillinases are widely distributed among clinically relevant gram-negative species. OXA-48 shows a hydrolysis profile that includes penicillins, carbapenems and cephalosporins [13] . OXA-24 and OXA-23 are a class D β-lactamase with carbapenemhydrolyzing activity that commonly isolated from a multi-drug resistant Acinetobacterbaumannii [14, 15] . Carbapenemases class D such as OXA-23, OXA-24, and OXA-48 are always associated with low levels of resistance to carbapenems such as meropenem, imipenem and doripenem [16] .
AIM
The aim of this study was to determine the multi-drug resistance (MDR) and ESBLs pro ducing E. coli strains, prevalence of class D carbapenemases among ESBLs producing Escherichia coli isolates from educational hospitals in Shahrekord, Iran.
MAterIAlS And MethOdS clinical Isolates
As E. coli is the most important causative agent of UTIs in both inpatients and outpatients [17] . In this study, E. coli strains isolated from UTI samples, including inpatients and outpatient, were examined. The isolates were collected from September 2013 to July 2014 in educational hospitals in Shahrekord, Iran.
Bacterial Identification and Susceptibility testing
Uropathogenic E. coli isolates were characterized through culture on respective mediums such as MacCo nkey agar, Blood agar p-values smaller than 0.05. We analysed the data with Statistical Package for the Social Sciences software for Windows Version 18.0 (SPSS, Inc., Chicago, IL, USA).
reSultS

Antimicrobial drug Susceptibility
During a 10-month period, 200 E. coli strains were isolated from UTIs of 100 from inpatients and 100 from outpatients. Although the resistance to antibiotic in isolated E. coli in outpatient urinary infection was remarkably lower than inpatient samples, this relationship was only significant for Ceftazidime (p<0.05) . Isolated MDR of the outpatients was 39% and of the inpatients was 60%. The results of statistical analysis by ChiSquare test showed that there was a significant relationship between the number of isolates that were resistant to multipledrug in two groups of inpatients and outpatients isolates (p=0.005). Nine antimicrobial agents are tested for all E. coli isolates and the obtained data are summarized in .
Prevalence of eSBl-producing E. coli Isolates
Out of 100 E. coli isolates from inpatients UTI, 60 isolates were multiple-drug resistant and 55 isolates were ESBL positive. Moreover, out of 100 E. coli isolates from outpatient UTI, 39 isolates were multiple-drug resistance and 35 were ESBL positive. DDST was applied to detect ESBL in E. coli isolates that were resistant to Ceftazidime using ceftazidime alone or with clavulanic acid. Of these, 55 (55%) isolates of inpatient and 35(35%) of outpatient were positive for production of ESBL. Statistical analysis suggested that there was a significant relationship between ESBLborne bacteria in outpatient and inpatient isolates (p=0.007). In this study, the prevalence of bacteria producing ESBLs in inpatient and outpatient isolates was 55% and 35%, respectively.
carbapenemases Genes detected
Multiplex PCR was applied to detect the presence of Class D carbapenemase genes, including bla OXA-23 , bla , and bla in E. coli isolates from inpatients and outpatient UTIs. The PCR products of 501 bp bla OXA-23 , 249 bp bla , and 307 bp bla and Eosin Methylene Blue agar (Hi Media, India), and biochemical tests. After incubation of plates at 35°C for 24 h, the pure isolates were identified by biochemical tests such as oxidative, catalase, citrate utilization, indole production, triple sugar iron agar, VogesProskauer and methyl red, as described in standard bacteriological methods. Antimicrobial susceptibility testing was performed by the Kirby-Bauer method in accordance with the Clinical and Laboratory Standards Institute (CLSI) recommendations. The antibiotic discs used in this study were amikacin 30 μg, ciprofloxacin 5 μg, nitrofurantoin 300 μg, norfloxacin10μg, Trimethoprim-sulfamethoxazole (1.25/23.75 μg) , nalidixic acid 30 μg, gentamicin 10μg, ceftazidime 30μg, and meropenem 10 μg (MAST Co., England). The protocol for antibiotic susceptibility test has been explained in the CLSI. The diameters of the inhibition zone were assessed and the isolates were classified as susceptible, intermediate, and resistant categories according to CLSI criteria [18] . The MDR bacteria were resistant to three or more antimicrobial classes [19] .
Phenotypic eSBl detection
ESBLs production was examined for the isolates that were resistant to one or more third generation cephalosporins (3GCs) by DDST using ceftazidime (30) and ceftazidime/clavulanic acid (30/10) (MAST Co. UK). A higher than or equal to 5 mm increase in diameter of the inhibition zone of the cephalosporin-plusclavulanate disc, when compared to the cephalospo rin only disc, was interpreted as phenotypic evidence of ESBLs production. K. pneumoniae ATCC 700603 and E. coli ATCC 25922 were used as positive and negative controls, respectively.
Preparation of dnA template for Pcr
Since most ESBL genes are plasmid borne, plasmid DNA was extracted and purified using the GeNet bio Plasmid kit (Plasmid DNA Isolation Kit, Korea). Plasmid DNA from these microorganisms was extracted from overnight bacterial growth in 5 ml Luria Bertani medium at 35±2˚C. The GeNet bio Plasmid kit protocol was used for bacterial plasmid isolation. Plasmid DNA concentrations were determined by the Nano Drop Spectrophotometer (Thermo Scientific, USA).
detection of OXA-type carbapenamases encoding Genes
All ESBL-producing E. coli isolates were screened by Multiplex PCR for the following β-lactamase encoding genes. Multiplex PCR was conducted for detection of the three families of OXA-type carbapenamases found in E.coli. Sequences of primers for the detection of gene encodings bla , bla , and bla OXA-48 genes are given in [Table/ Fig-1 ].
We also utilized the 16S rRNA gene as an internal control. The Multiplex PCR conditions are as follows: Initial denaturation at 95°C for 5 min, 35 cycles of 94 °C for 30 s, 56°C for 40 s and 72°C for 40 s, followed by a final extension step at 72°C for 5 min.
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StAtIStIcAl AnAlySIS
We compared the differences in susceptibility or resistance between the outpatient and inpatient with use of correlations between nominal variables. The data were assessed for significance by the Pearson Chi-square test or Fisher's-exact test. The differences between groups were considered significantly different with In inpatients E. coli isolates, the bla OXA-23 gene was detected in 21 (21% 
dIScuSSIOn
The issue of elevated bacterial resistance to antimicrobial agents and treatment of infectious diseases caused by these bacteria is a public health problem. In addition, the rate of bacterial resistance varies worldwide, nationwide and even among various geographical areas of a country [20] . In our study, all bacterial isolates were susceptible to meropenem. In a study by Gorgec et al., in Turkey, all the extended-spectrum beta-lactamase producing nosocomial E. coli isolates was susceptible to meropenem [21] . Besides, similar sensitive pattern were found in China and Nigeria [22, 23] . Because of stability issues encountered with some imipenem samples in gram negative bacteria, imipenem was replaced by meropenem in 2006 [24] . In the obtained results by disc diffusion method, E.coli isolated from urinary infections in inpatients and outpatients have shown the highest resistance to trimethoprim-sulfametoxazole (73.5) antibiotics and nalidixic acid (58.5%). Other studies also showed the highest resistance to trimethoprim-sulfametoxazole and nalidixic acid [25, 26] in E. coli samples collected from patients with UTIs.
In the obtained results by disc diffusion method, E.coli isolated from urinary infections in inpatients and outpatients have shown the highest resistance to Trimethoprim-sulfametoxazole antibiotics and nalidixic acid. In a study in Tehran, Iran Soltan Dallal et al., revealed a similar anti-bio gram pattern for trimethoprimsulfamethoxazole (80.5%), nalidixic acid (74%), ceftazidime (55.5%), and ciprofloxacin (55.5%) for 200 clinical isolates of E. coli. They also found that 70% of isolates were multi-drug resistant phenotype [25] .
Other studies also showed the highest resistance to trimethoprimsulfametoxazole and nalidixic acid [26, 27] in E. coli samples collected from patients with UTIs [28, 29] . But this pattern of resistance have been different in studies investigating drug resistance in strains of ESBL-producing E. coli compared to those study working upon the third generation of cephalosporins. For example, in a study by Gholiour et al., the level of antibiotic resistence for most studied antibiotics was lower than that of the present study. for example in a study that was performed by Gholipour et al., in Isfahan, Iran, the level of antibiotic resistance for most studied antibiotics was lower than that of the present study [26] .
During treatment of UTIs, whenever resistance to routinely used antibacterial happens, specific cephalosporins can be used for UTIs as alternatives [27] . But ESBL production rate by Enterobac teriaceae has increased considerably, which is the main problem with use of these cephalosporins [28] . Moreover, during recrudescent UTI, the carbapenem-resistant strains appear after long-term treatment with meropenem and imipenem. Since carbapenem antibiotics are often the drugs of choice for therapy of severe infections resulting from ESBL-producing E. coli, the incidence of carbapenem resistant E. coli is disturbing [29] . In the present study, the rate of antibiotic resistance in inpatient isolates was higher than outpatient, that is consistent with other studies [30] .
It can be inferred that further resistance of strains in hospital was due to greater consumption of antibiotics and antiseptics in hospital environments, resulting in higher levels of antibiotic resistant strains of hospital origin in outpatient's comparing to inpatients. were visualized by 8% polyacrylamide gel electrophoresis [Table /  Fig-4 ].
Even some debilitating illnesses such as severe sepsis can also cause antibiotic resistant gene transfer of exogenous pathogens resistant to susceptible endogenous pathogen during treatment with antibiotics that it demands multi-drug treatment against this pathogen [31, 32] .
In this study, the prevalence of ESBLs producing E. coli in out patients and inpatients UTI was 35% and 55%, respectively. Based on the finding of this study, the prevalence of ESBL producing E. coli was higher in inpatient isolates than in outpatient isolates. Similarly, researches from other countries demonstrated that the prevalence of ESBL-positive bacteria are more common in patients who, having a history of hospitalization, than in outpatients [31] .
In Isfahan, Iran, a study by Mobasherizadeh et al., revealed 44.1% and 21 .2% frequency for ESBL positive in E. coli strains isolated from inpatients and outpatients isolates [32] . Thus, our results were consistent with Mobasherizadeh et al., study and the frequency of ESBLs in bacteria isolated from inpatients was higher than that of outpatients. This suggests that infection control in hospitals could decrease the emergence of ESBL-producing bacteria and subsequently reduce the spread into societies. Various frequencies of ESBLs producing E. coli have been reported by some previous studies in Iran. In a study in Tehran, Soltan Dallal et al., showed that 115 (89.8%) E. coli isolates were identified as ESBLs producers [25] . In a study in Iran, Zaniani et al., revealed that 43.9% of E. coli was ESBL producers [33] .
In other countries, several studies have revealed that the distribution of ESBLs varies. For instance, in a study in Turkey by Bali et al., [34] , 42 of 50 E. coli strains (84%) isolated from different clinical samples were ESBL positive. The prevalence of the organisms in Poland was reported 49.3% in E. coli isolates [35] . The prevalence of ESBL-producing bacteria has been on the rise, mainly in Asia compared with other regions. Thus, the geographical distribution of ESBL-producing bacteria could vary among countries and settings [36] .
The prevalence of the OXA-23, OXA-24, and OXA-48 in our study was 21%, 18% and 11%, respectively for E. coli isolates from inpatient and 10%, 8% and 6%, respectively for E. coli isolates from outpatient. This difference is significant because the p-value of the Chi-Square is P < 0.001 and as mentioned above for ESBLs, the frequency of OXA type carbapenemase in bacteria isolated from inpatients was higher than that from outpatients.
In addition, the present study showed that OXA-23 and OXA-24 and OXA-48 were found more frequently in inpatients isolates, and that ESBL-positive bacteria was also more frequent in inpatients. In a study in India, the prevalence of OXA-48 gene was 32.6 in E. coli isolates, but OXA-23 and OXA-24 genes were not identified in the E. coli isolates [37] . These results are comparable to the results of other studies that have emphasized the spread of OXA-48-producing Enterobacteriaceae worldwide, especially in Europe, Africa and East-Central Asia [38, 39] .
In Iran, OXA-type carbapenemases was found more frequently in A.baumannii, P.aeruginosa and Enterobacteriaceae especially K. pneumonia, but no study has been yet investigated E. coli OXA producing isolates and to our knowledge, this is the first report of the frequency of OXA-type carbapenemases genes in E. coli isolates in Iran. In a study by Sohrabi et al., 
cOncluSIOn
It is quite alarming to note that many of the isolates included in this study were found as multiple drugs resistant. Antibiotic resistance has been appearing as a main issue in the management of inpatients and outpatients and increases the costs imposed on patients in health care systems. Briefly, the prevalence of ESBL-positive E.
coli isolates found in this study is of enormous concern that needs revision of infection control guidelines such as management of antibiotic prescription and traditional laboratory identification of ESBL-positive isolates to prevent ESBLs spread.
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